154 related articles for article (PubMed ID: 35018451)
41. A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer.
Wheless L; Kistner-Griffin E; Jorgensen TJ; Ruczinski I; Berthier-Schaad Y; Kessing B; Hoffman-Bolton J; Francis L; Shugart YY; Strickland PT; Kao WH; Alani RM; Smith MW; Alberg AJ
J Invest Dermatol; 2012 May; 132(5):1354-62. PubMed ID: 22336945
[TBL] [Abstract][Full Text] [Related]
42. The association of PTPN22 (rs2476601) and IL2RA (rs11594656) polymorphisms with T1D in Egyptian children.
Abdelrahman HM; Sherief LM; Abd Elrahman DM; Alghobashy A; Elsaadani HF; Mohamed RH
Hum Immunol; 2016 Aug; 77(8):682-686. PubMed ID: 27288719
[TBL] [Abstract][Full Text] [Related]
43. Behavior modification and risk perception in patients with nonmelanoma skin cancer.
Rhee JS; Davis-Malesevich M; Logan BR; Neuburg M; Burzynski M; Nattinger AB
WMJ; 2008 Apr; 107(2):62-8. PubMed ID: 18593080
[TBL] [Abstract][Full Text] [Related]
44. Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study.
Wang SH; Chi CC; Zhao ZH; Tung TH
Cancer Res Treat; 2018 Apr; 50(2):428-435. PubMed ID: 28494532
[TBL] [Abstract][Full Text] [Related]
45. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.
Amari W; Zeringue AL; McDonald JR; Caplan L; Eisen SA; Ranganathan P
Rheumatology (Oxford); 2011 Aug; 50(8):1431-9. PubMed ID: 21415022
[TBL] [Abstract][Full Text] [Related]
46. Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative.
Wysong A; Ally MS; Gamba CS; Desai M; Swetter SM; Seiffert-Sinha K; Sinha AA; Stefanick ML; Tang JY
Prev Med; 2014 Dec; 69():8-12. PubMed ID: 25150382
[TBL] [Abstract][Full Text] [Related]
47. An Analysis of IL-10/IL-10R Genetic Factors Related to Risk of Colon Cancer and Inflammatory Bowel Disease in a Han Chinese Population.
Cai J; Zhang Z
Clin Lab; 2016; 62(6):1147-54. PubMed ID: 27468578
[TBL] [Abstract][Full Text] [Related]
48. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking.
Costenbader KH; Chang SC; De Vivo I; Plenge R; Karlson EW
Arthritis Res Ther; 2008; 10(3):R52. PubMed ID: 18462498
[TBL] [Abstract][Full Text] [Related]
49. TIMP3 Gene Polymorphisms of -1296 T > C and -915 A > G Increase the Susceptibility to Arsenic-Induced Skin Cancer: A Cohort Study and In Silico Analysis of Mutation Impacts.
Wu MM; Chen CW; Chen CY; Lee CH; Chou M; Hsu LI; Lee TC; Chen CJ
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499314
[TBL] [Abstract][Full Text] [Related]
50. Tumor necrosis factor receptor II and PTPN22 genes polymorphisms and the risk of systemic lupus erythematosus in Egyptian children.
Eid R; Hammad A; Abdelsalam M; Fathy AA; Abd-El Ghafaar DM; Elmarghany EB; El-Hanafy AA; Mostafa N; Niazey NA; Korkor MS; Hamdy N
Lupus; 2021 Aug; 30(9):1449-1458. PubMed ID: 34080911
[TBL] [Abstract][Full Text] [Related]
51. Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.
Silverberg JI; Ratner D
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1389-97. PubMed ID: 25491569
[TBL] [Abstract][Full Text] [Related]
52. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
53. Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: a meta-analysis.
Latiano A; Palmieri O; Valvano MR; Bossa F; Latiano T; Corritore G; DeSanto E; Andriulli A; Annese V
Inflamm Bowel Dis; 2007 Oct; 13(10):1212-9. PubMed ID: 17600378
[TBL] [Abstract][Full Text] [Related]
54. Non-Invasive Buccal Swab Gene Testing for Skin Cancer Risk.
Moy L; Lyons AB; Fox W; Glicksman MA; Moy R; Tung R
J Drugs Dermatol; 2019 May; 18(5):448-453. PubMed ID: 31141850
[TBL] [Abstract][Full Text] [Related]
55. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.
Troyanova P; Danon S; Ivanova T
Neoplasma; 2002; 49(2):81-5. PubMed ID: 12088110
[TBL] [Abstract][Full Text] [Related]
56. Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis.
Liu R; Wan Q; Zhao R; Xiao H; Cen Y; Xu X
Cancer Cell Int; 2021 Nov; 21(1):614. PubMed ID: 34809619
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire.
Applebaum KM; Karagas MR; Hunter DJ; Catalano PJ; Byler SH; Morris S; Nelson HH
Environ Health Perspect; 2007 Aug; 115(8):1231-6. PubMed ID: 17687452
[TBL] [Abstract][Full Text] [Related]
58. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
[TBL] [Abstract][Full Text] [Related]
59. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease.
Moran GW; Lim AW; Bailey JL; Dubeau MF; Leung Y; Devlin SM; Novak K; Kaplan GG; Iacucci M; Seow C; Martin L; Panaccione R; Ghosh S
Aliment Pharmacol Ther; 2013 Nov; 38(9):1002-24. PubMed ID: 24099467
[TBL] [Abstract][Full Text] [Related]
60. A BACH2 Gene Variant Is Associated with Postoperative Recurrence of Crohn's Disease.
Laffin MR; Fedorak RN; Wine E; Dicken B; Madsen KL
J Am Coll Surg; 2018 May; 226(5):902-908. PubMed ID: 29452228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
